ப்ரெட் ரோஸன் News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from ப்ரெட் ரோஸன். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In ப்ரெட் ரோஸன் Today - Breaking & Trending Today
RB Capital Partners, Inc. CEO Brett Rosen Funds ASCK $700K Factory Facility for Auscrete Corporation finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
Home Construction Demand Drives ASCK Auscrete Corporation's Factory and Equipment Expansion finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
Sunshine Biopharma Receives $0.9 Million in Additional Funding From RB Capital biospace.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from biospace.com Daily Mail and Mail on Sunday newspapers.
ISW Holdings Secures and Receives $8 Million in New Financing for Expanding Cryptocurrency Mining and Hosting Resources padovanews.it - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from padovanews.it Daily Mail and Mail on Sunday newspapers.
(2) MONTREAL, QC / ACCESSWIRE / January 14, 2021 / Sunshine Biopharma Inc. (OTC PINK:SBFM), a pharmaceutical company focused on the research, development and commercialization of oncology and antiviral drugs, today announced that it has received the fourth tranche of funding under the recently announced committed minimum financing of $2,000,000 with RB Capital Partners Inc. This brings the total to $1,050,000 that the Company has received to date under this financing. The proceeds will be used for the ongoing development of the Company s Coronavirus Treatment on a priority basis and the clinical development of Adva-27a, the Company s flagship anticancer compound targeted for pancreatic cancer. Sunshine Biopharma Inc. CFO, Camille Sebaaly stated, As a company, we continue to forge forward in our development of a COVID treatment and our anticancer compounds. This investment capital has been integral to our progress in each of these sectors. ....